1st Quarter - Report
BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
Client
Income
—
Expenses
$220,000
Expense method
C: businesses, Internal Revenue Code section 162(e)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
NIH Funding FDA Funding PEPFAR
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
| ELIZABETH WOODY | — |
Health Issues HCR
Healthcare policy and medical technology issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
| ELIZABETH WOODY | — |
Taxation/Internal Revenue Code TAX
H.R.523, Protect Medical Innovation Act of 2013 S.232, Medical Device Access and Innovation Protection Act Device tax amendment Corporate tax issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
| ELIZABETH WOODY | — |
Medicare/Medicaid MMM
Diagnostic reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| ELIZABETH WOODY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.